Works matching DE "PROGRESSION-free survival"

Results: 5000
    1
    2
    3
    4

    Intraoperatively preventive intraperitoneal perfusion chemotherapy with lobaplatin in colorectal cancer: a prospective, randomised, controlled, multicentre study.

    Published in:
    BMC Medicine, 2025, v. 23, n. 1, p. 1, doi. 10.1186/s12916-025-04180-1
    By:
    • Su, Hao;
    • Zhang, Rui;
    • Li, Yunfeng;
    • Li, Yanke;
    • Pei, Wei;
    • Jie, Zhigang;
    • Liu, Zhimin;
    • Huang, Meijin;
    • Zhuang, Jing;
    • Jiang, Qian;
    • Xie, Ming;
    • Wang, Guiying;
    • Zhang, Wenbin;
    • Liu, Ming;
    • Chen, Jiansi;
    • Wang, Zejun;
    • Wang, Kang;
    • Zhang, Xinghong;
    • Li, Guoxin;
    • Zeng, Xiangfu
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20

    Gemcitabine and docetaxel for high‐risk non‐muscle‐invasive bladder cancer: EuroGemDoce group results.

    Published in:
    BJU International, 2025, v. 135, n. 6, p. 969, doi. 10.1111/bju.16645
    By:
    • Scilipoti, Pietro;
    • Longoni, Mattia;
    • de Angelis, Mario;
    • Zaurito, Paolo;
    • Massiet, Albane;
    • Dutto, Daniele;
    • Soria, Francesco;
    • Álvarez‐Maestro, Mario;
    • Bazán, Alfredo Aguilera;
    • Pradere, Benjamin;
    • Klatte, Tobias;
    • Contieri, Roberto;
    • Hurle, Rodolfo;
    • Krajewski, Wojciech;
    • Subiela, José Daniel;
    • Pichler, Renate;
    • Szostek, Aleksandra;
    • Marcq, Gautier;
    • Elena, José Luis Rodríguez;
    • Aranda, Javier
    Publication type:
    Article
    21
    22
    23
    24

    Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation for Diffuse Cutaneous Systemic Sclerosis: Identifying Disease Risk Factors for Toxicity and Long‐Term Outcomes in a Prospective, Single‐Arm Trial.

    Published in:
    Arthritis & Rheumatology, 2025, v. 77, n. 5, p. 571, doi. 10.1002/art.43072
    By:
    • Georges, George E.;
    • Khanna, Dinesh;
    • Wener, Mark H.;
    • Mei, Matthew G.;
    • Mayes, Maureen D.;
    • Simms, Robert W.;
    • Sanchorawala, Vaishali;
    • Hosing, Chitra;
    • Kafaja, Suzanne;
    • Pawarode, Attaphol;
    • Holmberg, Leona A.;
    • Kolfenbach, Jason;
    • Furst, Daniel E.;
    • Sullivan, Keith M.;
    • Huang, Suiyuan;
    • Gooley, Ted;
    • Nash, Richard A.
    Publication type:
    Article
    25
    26
    27

    Circulating tumor DNA dynamic variation predicts sotorasib efficacy in KRASp.G12C‐mutated advanced non‐small cell lung cancer.

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 11, p. 1, doi. 10.1002/cncr.35917
    By:
    • Passiglia, Francesco;
    • Pepe, Francesco;
    • Russo, Gianluca;
    • Garbo, Edoardo;
    • Listì, Angela;
    • Benso, Federica;
    • Scimone, Claudia;
    • Palumbo, Lucia;
    • Pluchino, Monica;
    • Minari, Roberta;
    • Bordi, Paola;
    • Cani, Massimiliano;
    • Ungaro, Antonio;
    • Ambrogio, Chiara;
    • Taulli, Riccardo;
    • Capelletto, Enrica;
    • Balbi, Maurizio;
    • Righi, Luisella;
    • Tiseo, Marcello;
    • Giannarelli, Diana
    Publication type:
    Article
    28
    29

    A low lymphocyte‐to‐monocyte ratio is independently associated with early relapse (POD24) in high tumour burden follicular lymphoma: A RELEVANCE subanalysis.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 5, p. 1380, doi. 10.1111/bjh.20038
    By:
    • Mozas, Pablo;
    • Ould Ammar, Romain;
    • Chartier, Loïc;
    • Nastoupil, Loretta;
    • Bachy, Emmanuel;
    • Bezsera, Silvia Maria;
    • Barnes, Jeffrey;
    • Bijou, Fontanet;
    • Goy, André;
    • Zerazhi, Hacène;
    • Cartron, Guillaume;
    • Ojeda‐Uribe, Mario;
    • Choquet, Sylvain;
    • Joly, Bertrand;
    • Cheminant, Morgane;
    • Martín García‐Sancho, Alejandro;
    • Eradat, Herbert;
    • Gressin, Rémy;
    • Abrisqueta, Pau;
    • Parcelier, Anne
    Publication type:
    Article
    30
    31
    32

    Changing metastatic patterns associate with dynamics of circulating tumor DNA in metastatic castration-resistant prostate cancer.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf107
    By:
    • Conteduca, Vincenza;
    • Scarpi, Emanuela;
    • Rossi, Alice;
    • Ferroni, Fabio;
    • Gurioli, Giorgia;
    • Bleve, Sara;
    • Gianni, Caterina;
    • Schepisi, Giuseppe;
    • Brighi, Nicole;
    • Lolli, Cristian;
    • Cursano, Maria Concetta;
    • Virga, Alessandra;
    • Casadei, Chiara;
    • Altavilla, Amelia;
    • Farolfi, Alberto;
    • Ulivi, Paola;
    • Barone, Domenico;
    • Matteucci, Federica;
    • Giorgi, Ugo De
    Publication type:
    Article
    33
    34
    35

    Evaluation of the effectiveness and safety of avapritinib in real-world Spanish cases with gastrointestinal stromal tumor and D842V-PDGFRA mutation.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf062
    By:
    • Hernández, Isaac Nuñez;
    • Palmero, Cristina Gómez;
    • Delgado, Juan Ramón;
    • Nuño, Ana;
    • González, Maria Ángeles Sala;
    • Ageitos, Ana González;
    • Aguilar, Héctor;
    • Miguel, Pablo Ayala de;
    • Condori, Elizabeth;
    • Beveridge, Roberto Díaz;
    • García, Jerónimo Martínez;
    • Marquina, Gloria;
    • Varela-Pose, Vanesa;
    • Rodríguez, Joel Veas;
    • Serrano, César
    Publication type:
    Article
    36
    37

    PARP inhibitors as maintenance therapy in ovarian cancer after platinum-sensitive recurrence: real-world experience from the Unicancer network.

    Published in:
    Oncologist, 2025, v. 30, n. 5, p. 1, doi. 10.1093/oncolo/oyaf075
    By:
    • Rippstein, Nicolas;
    • Zemmour, Christophe;
    • Rodrigues, Manuel;
    • Ray-Coquard, Isabelle;
    • Gladieff, Laurence;
    • Pautier, Patricia;
    • Frénel, Jean-Sébastien;
    • Costaz, Hélène;
    • Lebreton, Coriolan;
    • Pomel, Christophe;
    • Colombo, Pierre-Emmanuel;
    • Marchal, Frédéric;
    • Guillemet, Cécile;
    • Rouge, Thibault de la Motte;
    • Eberst, Lauriane;
    • Bosquet, Lise;
    • Deluche, Elise;
    • Sabatier, Renaud
    Publication type:
    Article
    38
    39
    40
    41
    42
    43

    Cost-Effectiveness of Elranatamab Versus Current Therapies for the Management of Patients with Triple-Class Exposed, Relapsed and Refractory Multiple Myeloma, Including Other Bispecific and Physician's Choice of Treatment in Spain.

    Published in:
    Oncology & Therapy, 2025, v. 13, n. 2, p. 381, doi. 10.1007/s40487-025-00333-7
    By:
    • Encinas, Cristina;
    • Lozano, Virginia;
    • Hlavacek, Patrick;
    • Llinares, Julia;
    • Toribio-Castelló, Sofía;
    • Carcedo, David;
    • Asís-Montalt, Jordi;
    • Martínez-López, Joaquín
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50